Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Incannex Healthcare (IXHL) Invested Capital (2020 - 2025)

Incannex Healthcare's Invested Capital history spans 4 years, with the latest figure at $73.4 million for Q4 2025.

  • On a quarterly basis, Invested Capital rose 2091.88% to $73.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $73.4 million, a 2091.88% increase, with the full-year FY2025 number at $13.4 million, up 19.36% from a year prior.
  • Invested Capital hit $73.4 million in Q4 2025 for Incannex Healthcare, down from $77.0 million in the prior quarter.
  • Over the last five years, Invested Capital for IXHL hit a ceiling of $77.0 million in Q3 2025 and a floor of $3.3 million in Q4 2024.
  • Historically, Invested Capital has averaged $24.3 million across 3 years, with a median of $14.1 million in 2024.
  • Biggest five-year swings in Invested Capital: crashed 82.25% in 2024 and later surged 2091.88% in 2025.
  • Tracing IXHL's Invested Capital over 3 years: stood at $18.9 million in 2023, then crashed by 82.25% to $3.3 million in 2024, then surged by 2091.88% to $73.4 million in 2025.
  • Business Quant data shows Invested Capital for IXHL at $73.4 million in Q4 2025, $77.0 million in Q3 2025, and $13.4 million in Q2 2025.